Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$695,115
+$14,106 QoQ
Shares Held
2,737
-1.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#3,363
of 4,664 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CONSILIO WEALTH ADVISORS, LLC holds $3,117,860 across 5 Drug Manufacturers - General names. JNJ ranks #2 (22.3% of the industry book) .
All Filings in JNJ
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $695,115 | 2,737 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $681,009 | 2,786 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $563,524 | 2,723 | Shares | Sole | 2026-03-20 | |
| 2025-09-30 | $495,442 | 2,672 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $349,797 | 2,290 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $410,454 | 2,475 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $292,132 | 2,020 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $337,084 | 2,080 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $201,993 | 1,382 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $298,188 | 1,885 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $279,780 | 1,785 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $222,411 | 1,428 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $203,589 | 1,230 | Shares | Sole | 2023-07-13 | |
| 2022-12-31 | $209,153 | 1,184 | Shares | Sole | 2023-01-25 | |
| No filing history on record for this holder in this stock. | ||||||